Appendix F. Chapter References
This appendix collects the reference lists for chapters 1 through 13. In-text citations throughout the book use bracketed numbers (e.g., [1]) that correspond to the numbered entries below, organized by chapter. Appendixes C, D, and I carry their own reference lists at the end of each appendix.
F.1 Chapter 1 References
[1] Progress on the HUPO Draft Human Proteome: 2017 Metrics of the Human Proteome Project. Gilbert S. Omenn, Lydie Lane, Emma K. Lundberg, Christopher M. Overall, and Eric W. Deutsch. Journal of Proteome Research 2017 16 (12), 4281-4287. DOI: 10.1021/acs.jproteome.7b00375
[2] Macarron, R., Banks, M., Bojanic, D. et al. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov 10, 188–195 (2011). https://doi.org/10.1038/nrd3368
[3] DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20–33. https://doi.org/10.1016/j.jhealeco.2016.01.012
[4] Bohacek, R.S., McMartin, C. and Guida, W.C. (1996), The art and practice of structure-based drug design: A molecular modeling perspective. Med. Res. Rev., 16: 3-50. https://doi.org/10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6
[5] Reymond, J.L. (2015), The Chemical Space Project. Acc. Chem. Res., 48 (3): 722-730. https://doi.org/10.1021/ar500432k